What is CG Oncology's current ratio?

CG Oncology (CGON) reported current ratio of 31.3× in Q1 2026.

How has CG Oncology's current ratio changed year-over-year?

CG Oncology's current ratio increased by 1.1% year-over-year, from 31× to 31.3×.

What is the long-term trend for CG Oncology's current ratio?

Over 2 years (2023 to 2025), CG Oncology's current ratio has grown at a 34.5% compound annual growth rate (CAGR), from 13.6× to 24.6×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

CG Oncology CGON Current ratio

Current ratio at other companies

PfizerPFE

1.2×0.0×

Johnson & JohnsonJNJ

1×-0.2×

Gilead SciencesGILD

2×+0.6×

ImmunityBio, Inc.IBRX

6.7×+4.4×

Cogent Biosciences, Inc.COGT

15.1×+10.0×

Tango TherapeuticsTNGX

27.4×+21.1×

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Where this comes from

Calculated from CG Oncology’s reported figures.

total current assets/total current liabilities=31.3×

Based on the most recent quarter.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's current ratio?: CG Oncology (CGON) reported current ratio of 31.3× in Q1 2026.
How has CG Oncology's current ratio changed year-over-year?: CG Oncology's current ratio increased by 1.1% year-over-year, from 31× to 31.3×.
What is the long-term trend for CG Oncology's current ratio?: Over 2 years (2023 to 2025), CG Oncology's current ratio has grown at a 34.5% compound annual growth rate (CAGR), from 13.6× to 24.6×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.